Understanding Injections for Macular Degeneration: A Guide for Indian Patients

What is Macular Degeneration?

Macular degeneration, often referred to as age-related macular degeneration (AMD), is a common cause of vision loss, particularly among older adults in India and around the world. It affects the macula, a small part of the retina responsible for sharp, central vision, which is crucial for reading, driving, and recognizing faces. AMD has two primary forms: dry AMD and wet AMD. While dry AMD progresses slowly and is more common, wet AMD, though less frequent, can lead to rapid and severe vision loss.

Understanding Wet Macular Degeneration and the Role of Injections

In wet AMD, abnormal blood vessels grow beneath the macula. These fragile vessels can leak blood and fluid, causing damage to the macula and leading to distorted or lost central vision. This is where anti-VEGF injections come into play as a revolutionary treatment. Anti-VEGF stands for anti-vascular endothelial growth factor. VEGF is a protein that encourages the growth of new blood vessels. In wet AMD, there's an overproduction of VEGF, leading to the formation of these problematic leaky vessels. Anti-VEGF medications work by blocking the action of this protein, thereby inhibiting the growth and leakage of these abnormal blood vessels.

Types of Anti-VEGF Medications Used in India

Several anti-VEGF medications are available and commonly used for treating wet AMD. The choice of medication often depends on factors like the specific condition, the patient's response, and availability. Some of the prominent options include:

• Ranibizumab (Lucentis): One of the first anti-VEGF drugs approved for AMD, it is effective in slowing down vision loss and sometimes improving vision.
• Aflibercept (Eylea): Similar to ranibizumab, aflibercept is highly effective in treating wet AMD by inhibiting VEGF.
• Bevacizumab (Avastin): While originally approved for cancer treatment, Avastin is widely used off-label for AMD due to its effectiveness and lower cost, making it a popular choice in India.
• Brolucizumab (Beovu): A newer option that may allow for less frequent injections in some cases.
• Faricimab-svoa (Vabysmo): This medication targets both VEGF and another pathway involved in blood vessel growth, potentially offering a different mechanism of action.

Your eye specialist in India will discuss the best option for your specific needs, considering factors like cost, insurance coverage, and individual response.

The Injection Procedure: What to Expect

Receiving an anti-VEGF injection is a relatively quick and usually painless procedure performed by an ophthalmologist or a trained eye care professional. Here’s a step-by-step breakdown:

1. Preparation: Your eye will be cleaned thoroughly with an antiseptic solution to prevent infection. Numbing eye drops will be administered to ensure you don't feel pain during the injection.
2. Eyelid Stabilization: An instrument called an eye speculum may be used to gently hold your eyelids open, ensuring you don't blink during the procedure.
3. The Injection: You'll be asked to look away from the syringe. The medication is then injected directly into the vitreous gel (the clear, jelly-like substance filling the eye) using a very fine needle. The entire injection process takes only a few seconds.
4. Post-Injection Care: After the injection, the eye care professional will gently clean the injection site. You might be advised to avoid rubbing your eye for a short period.

Most patients report minimal to no discomfort during the procedure. Some may experience a brief sensation of pressure.

Frequency and Schedule of Injections

The number of injections and the frequency at which you receive them are highly individualized. Initially, injections are often given every 4 to 8 weeks. However, this schedule can be adjusted based on how your eye responds to the treatment, the specific medication used, and the dosage. Some individuals may require more frequent injections, while others might be able to extend the intervals between treatments. Regular follow-up appointments are crucial to monitor your progress and determine the optimal treatment schedule.

Effectiveness of Anti-VEGF Injections

Anti-VEGF injections are considered a highly effective treatment for wet AMD. Studies and clinical experience show that:

• Vision Improvement: Approximately one in three people who receive these injections experience an improvement in their vision.
• Preventing Further Vision Loss: A significant majority, around 9 out of 10 people, can prevent their vision from worsening with these treatments.

It's important to understand that these injections are designed to halt or slow down the progression of the disease and, in many cases, improve vision. However, they may not be suitable for individuals with very advanced wet AMD where significant vision loss has already occurred. Furthermore, research is ongoing, and some newer injections are showing promise for dry AMD as well.

Potential Risks and Side Effects

While generally safe and effective, like any medical procedure, anti-VEGF injections carry some potential risks and side effects. These are relatively uncommon but important to be aware of:

• Infection: There is a small risk of infection inside the eye (endophthalmitis). Strict sterile techniques are used to minimize this risk.
• Inflammation: Some inflammation within the eye can occur.
• Increased Eye Pressure: Temporary increases in intraocular pressure can happen.
• Retinal Detachment: In rare cases, retinal detachment can occur.
• Allergic Reaction: Although rare, an allergic reaction to the medication is possible.

Your doctor will discuss these risks with you in detail and monitor you closely for any signs of complications. Promptly report any new or worsening symptoms, such as increased eye pain, redness, sensitivity to light, or changes in vision, to your doctor.

Cost and Accessibility in India

The cost of anti-VEGF injections can be a significant concern for many patients in India. The price varies depending on the specific drug, the number of injections required, and whether you have health insurance. While some medications like Avastin (bevacizumab) are more affordable due to their off-label use, others can be quite expensive. Many government health schemes and private insurance policies in India offer coverage for AMD treatments, including these injections. It is advisable to:

• Consult Your Doctor: Discuss the cost implications and available options with your ophthalmologist.
• Check Insurance Coverage: Verify what your health insurance policy covers regarding AMD treatments.
• Explore Financial Assistance: Inquire about patient assistance programs offered by pharmaceutical companies or charitable organizations.

When to Consult a Doctor

If you are experiencing symptoms of macular degeneration, such as:

• Blurred or distorted central vision
• Difficulty reading or recognizing faces
• A dark or blank spot in the center of your vision

It is crucial to consult an eye specialist (ophthalmologist) immediately. Early diagnosis and treatment are key to preserving vision. If you are already undergoing treatment with anti-VEGF injections, contact your doctor right away if you notice any of the following:

• Sudden increase in eye pain or redness
• Increased sensitivity to light
• New or worsening floaters (specks or cobwebs in your vision)
• Sudden decrease in vision

Frequently Asked Questions (FAQ)

Q1: Are anti-VEGF injections a cure for macular degeneration?

A: Anti-VEGF injections are not a cure for macular degeneration, but they are a highly effective treatment for wet AMD. They aim to stop or slow down the progression of the disease and can help preserve or even improve vision in many patients.

Q2: Can I receive these injections for dry AMD?

A: Traditionally, anti-VEGF injections were primarily for wet AMD. However, research is advancing, and some newer treatments and injections are showing promise for managing dry AMD, although they are not as established as treatments for wet AMD.

Q3: How long do the effects of the injections last?

A: The effects of the injections are not permanent. The medication gradually leaves the eye, which is why regular injections are needed. The frequency is determined by how well your eye responds to treatment and the specific drug used.

Q4: Is it possible to have vision loss even with these injections?

A: While these injections are very effective at preventing further vision loss, they may not restore vision that has already been lost due to advanced disease. In some rare cases, vision loss can still occur despite treatment. Early detection and consistent treatment are vital.

Q5: What are the long-term implications of regular eye injections?

A: Anti-VEGF injections have been used for many years and are considered safe for long-term use when administered by trained professionals. The main concern is the need for repeated procedures, but the benefits in preserving vision generally outweigh the risks for individuals with wet AMD.